Project Grant R01HL173035
- The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded a $429,000 Project Grant to the Regents of the University of Michigan to develop a rapid, contrast-free, 3D whole-lung low-field MRI protocol for the detection of pulmonary embolism (PE). The goal of this 26-month project is to leverage advancements in low-field MRI and deep learning denoising techniques to create an efficient, radiation-free alternative to computed...
- This Cooperative Agreement award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will develop advanced pulmonary magnetic resonance imaging (MRI) methods on a novel 0.55 Tesla MRI system. The $659,644 project aims to: 1) Improve spatial resolution and image contrast of structural lung proton MRI; 2) Develop hyperpolarized xenon MRI capabilities for this low-field MRI system; and 3) Deploy and validate these methods...
- This $1,336,000 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program supports the development of a rapid, motion-robust, and low-gadolinium MRI technology for pediatric brain tumors. The key objectives are to (1) develop cutting-edge technologies for rapid, motion-robust, and quantitative MRI scans to reduce sedation needs...
- This $739,466 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to develop a comprehensive PET attenuation correction scheme for cardiac PET/MR imaging. The key products and services to be delivered include: Fabricating a device to rapidly position and remove an external PET source in a PET/MR system for practical and safe patient imaging. Developing algorithms for real-time hardware optimization and deep learning...
- This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $642,000 to develop an automated assessment pipeline for pediatric radiographs to identify malposition of peripherally inserted central catheters (PICCs) in critically ill children. The 3-year project aims to leverage deep learning algorithms to (1) segment PICC...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $468,000 Project Grant under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) to the University of Colorado-Denver for the "Secondary Analysis of Noninvasive Imaging Biomarkers for the Early Prediction of Single Ventricle Failure" project. This 2-year research project aims to noninvasively quantify systemic and pulmonary vascular compliance through novel analysis of magnetic resonance imaging...
- This $704,234 federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will support the development of an end-to-end deep learning pipeline for accelerating 4D flow MRI acquisition and automated hemodynamic analysis in patients with bicuspid aortic valve (BAV) disease. The grant will leverage a large database of over 4,000 manually processed 4D flow MRI scans at Northwestern University to train and validate the deep learning...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $511,583 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The Children's Hospital Corporation (doing business as Boston Children's Hospital) for the project "Motion and Distortion-Robust Quantitative MRI of Early Brain Developments". The objective is to develop an innovative, motion- and distortion-robust quantitative MRI...
- The National Heart, Lung, and Blood Institute, under the Cardiovascular Diseases Research program (CFDA 93.837), awarded a $870,467 project grant to Ension Inc. to develop an innovative bearingless (magnetically levitated) flux reversal motor for neonatal and pediatric extracorporeal life support applications. The funded project aims to address shortcomings of the currently available bearingless pediatric blood pump, the Abbott Pedimag, by creating an advanced compact extracorporeal life support...
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $783,801 to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to demonstrate the feasibility of a "democratized and comprehensive cardiac imaging protocol" using a push-button, time-resolved 3D cardiac MRI (AutoCMR) and automated report generation (CMR-Target) for heart failure diagnosis in underserved community family...
PEDIATRIC CARDIOPULMONARY MRI USING RF NAVIGATORS AND HIGH DIMENSIONAL DEEP LEARNING - ABSTRACT THE CARDIAC AND PULMONARY SYSTEMS ARE INHERENTLY LINKED THROUGH THE PULMONARY VASCULAR SYSTEM WHICH LEADS TO SECONDARY PULMONARY DISEASE IN CASES OF CARDIAC PATHOLOGY. THIS IS ESPECIALLY THE CASE IN CONGENITAL HEART DISEASE WHERE THE PULMONARY BLOOD SUPPLY IS OFTEN SUBSTANTIALLY ALTERED BY ABNORMAL OUTFLOW TRACTS AND VENTRICULAR FORMATION. CROSS-SECTIONAL IMAGING HAS PROVEN TO BE INVALUABLE FOR ASSESSING PEDIATRIC DISEASES, INCLUDING CONGENITAL HEART DISEASE; HOWEVER, CURRENT CARDIOPULMONARY EVALUATIONS TYPICALLY REQUIRE MULTIPLE EXAMS (SPECT, ECHO, MRI, AND CT) TO EVALUATE THE CARDIOVASCULAR AND PULMONARY SYSTEMS. EACH EXAM ADDS RISK TO ALREADY FRAGILE PATIENTS, INTRODUCES COMPLEX LOGISTICS OF PERFORMING MULTIPLE EXAMS, AND CAN DELAY CARE OF PATIENTS WHO MAY REQUIRE URGENT MANAGEMENT. OFTEN, ONLY A SUBSET OF EXAMS ARE PERFORMED, AND CLINICAL MANAGEMENT IS BASED ON INCOMPLETE INFORMATION AND DISREGARDS THE STRONG POTENTIAL FOR CARDIOPULMONARY COUPLING. IN THIS PROJECT, WE AIM TO DEVELOP MRI METHODS THAT CAN SIMULTANEOUSLY AND EFFICIENTLY EVALUATE BOTH ANATOMY AND FUNCTION IN PEDIATRIC CARDIOPULMONARY DISEASES. MRI IS THEORETICALLY WELL SUITED FOR QUANTITATIVELY IMAGING BOTH THE CARDIAC AND RESPIRATORY SYSTEMS BUT IS TRADITIONALLY CHALLENGED BY ITS SLOW IMAGING SPEED AND SENSITIVITY TO ARTIFACTS. RECENTLY, OUR GROUP HAS PROPOSED METHODS FOR DRAMATICALLY MORE ROBUST LUNG IMAGING USING THE COMBINATION OF ULTRASHORT ECHO TIME MRI WITH ADVANCED MOTION CORRECTED RECONSTRUCTION STRATEGIES. IN THIS PROPOSAL, WE EXTEND THESE TECHNIQUES AND INTRODUCE NOVEL METHODS TO PROVIDE IMPROVED AND COMPREHENSIVE DIAGNOSTICS OF THE ENTIRE CARDIOPULMONARY SYSTEM. FIRST, WE INTRODUCE A FREE-RUNNING APPROACH TO CARDIOPULMONARY IMAGING TO PROVIDE ANATOMICAL IMAGING AND THE QUANTIFICATIONS OF VENTILATION, PERFUSION, CARDIAC FUNCTION, AND RESPIRATORY RESOLVED CARDIAC FLOW DYNAMICS. WE SPECIFICALLY AIM TO IMAGE CONTINUOUSLY WITH T1 WEIGHTED AND VELOCITY ENCODED SEQUENCES, AND SUBSEQUENTLY RECONSTRUCT THIS DATA WITH A HIGH-DIMENSIONAL DEEP LEARNING APPROACH. THE RECONSTRUCTIONS USE NOVEL MOTION CORRECTED METHODS TO DIRECTLY ESTIMATE IMAGES AND APPLY DEEP LEARNING IN A HIGHLY COMPRESSED SPACE. SECONDLY, WE AIM TO DEVELOP NEXT-GENERATION MOTION MANAGEMENT USING AN RF NAVIGATOR TECHNIQUE, BEAT PILOT TONE, THAT CAN BE APPLIED DURING ANY PULSE SEQUENCE TO MEASURE BULK, RESPIRATORY AND CARDIAC MOTION. BEAT PILOT TONE PROVIDES A BASIS FOR MOTION TRACKING THAT ENABLES IMPROVED IMAGING EFFICIENCY, A SIMPLIFIED SETUP WITHOUT CARDIAC LEADS OR RESPIRATORY BELTS, AND MUCH BETTER MEASURES OF BULK MOTION. THESE TECHNIQUES WILL BE EVALUATED IN NORMAL CONTROL PARTICIPANTS AND PEDIATRIC SUBJECTS WITH CONGENITAL HEART DISEASE, EACH WITH COMPARISONS TO STATE-OF-THE-ART IMAGING. THE IMPACT OF THIS PROJECT IS TO SHIFT THE PARADIGM FOR CLINICAL MANAGEMENT OF CARDIOPULMONARY DISEASES TO A SINGLE-SCAN COMPREHENSIVE IMAGING STUDY AND SUPPORTING AN INTEGRATED ASSESSMENT OF INTERACTION BETWEEN THE PULMONARY AND CARDIAC SYSTEMS IN DISEASE. WHILE THIS IS TARGETED AT PEDIATRIC CARDIOPULMONARY DISEASES, THE INNOVATIONS CAN BE APPLIED BROADLY TO MRI STUDIES THROUGHOUT AGE RANGES AND TO OTHER STUDIES THAT SUFFER FROM MOTION ARTIFACTS THROUGHOUT THE BODY.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $70.1k | 7/18/25 | ||
| Not listed | $630.6k | 3/28/25 | ||
| Not listed | $630.6k | 3/28/25 | ||
| Not listed | $754.3k | 6/14/24 | ||
| Not listed | $754.3k | 6/14/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
0000003820S | The Regents Of The University Of California. San Francisco | Project Grant R01HL173035 | $180.1k | 12/16/24 | |
0000003818S | The Leland Stanford Junior University | Project Grant R01HL173035 | $328.2k | 11/15/24 | |
0000003819S | The Regents Of The University Of California | Project Grant R01HL173035 | $180.5k | 9/19/24 |